Skip to main content
. 2021 Sep 15;13(9):1472. doi: 10.3390/pharmaceutics13091472

Table 2.

Physical characterization of solid lipid nanoparticles (SLNs).

SLNs Size (nm) PDI ζ-Potential (mV)
SLNEE 198.7 ± 2.0 0.26 ± 0.01 +57.8 ± 1.7
SLNHM 93.3 ± 0.4 0.28 ± 0.01 +68.5 ± 0.7
SLNC 307.8 ± 3.5 0.17 ± 0.01 +21.1 ± 0.8

DX: dextran; HA: hyaluronic acid; SLNEE: solid lipid nanoparticle prepared by emulsification-evaporation method. SLNHM: solid lipid nanoparticle prepared by hot-melt emulsification method. SLNC: solid lipid nanoparticle prepared by coacervation method. PDI: polydispersity index. Data are expressed as mean ± standard deviation; n = 3.